Cargando…
Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content
Digital therapeutics (DTx) are software programs that treat a disease or condition. Increasingly, DTx are part of medical care, and in the US healthcare system they are regulated by the FDA as Software as a Medical Device (SaMD). Randomized controlled trials (RCT) remain a key evidence generation st...
Autores principales: | Lutz, Jacqueline, Offidani, Emanuela, Taraboanta, Laura, Lakhan, Shaheen E., Campellone, Timothy R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436387/ https://www.ncbi.nlm.nih.gov/pubmed/36060538 http://dx.doi.org/10.3389/fdgth.2022.823977 |
Ejemplares similares
-
Assessing the Potential Risks of Digital Therapeutics (DTX): The DTX Risk Assessment Canvas
por: Denecke, Kerstin, et al.
Publicado: (2023) -
Editorial: Digital therapeutics: using software to treat, manage, and prevent disease
por: Smayda, Kirsten E., et al.
Publicado: (2023) -
A Virtual, Randomized, Control Trial of a Digital Therapeutic for Speech, Language, and Cognitive Intervention in Post-stroke Persons With Aphasia
por: Braley, Michelle, et al.
Publicado: (2021) -
A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB‐DH1 trial
por: Kario, Kazuomi, et al.
Publicado: (2020) -
Digital Therapeutics: Exploring the Possibilities of Digital Intervention for Myopia
por: Lee, Yong Sun, et al.
Publicado: (2021)